Literature DB >> 20980664

A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program.

Mohammad Q Hassan1, Jonathan A R Gordon, Marcio M Beloti, Carlo M Croce, Andre J van Wijnen, Janet L Stein, Gary S Stein, Jane B Lian.   

Abstract

Induced osteogenesis includes a program of microRNAs (miRs) to repress the translation of genes that act as inhibitors of bone formation. How expression of bone-related miRs is regulated remains a compelling question. Here we report that Runx2, a transcription factor essential for osteoblastogenesis, negatively regulates expression of the miR cluster 23a∼27a∼24-2. Overexpression, reporter, and chromatin immunoprecipitation assays established the presence of a functional Runx binding element that represses expression of these miRs. Consistent with this finding, exogenous expression of each of the miRs suppressed osteoblast differentiation, whereas antagomirs increased bone marker expression. The biological significance of Runx2 repression of this miR cluster is that each miR directly targets the 3' UTR of SATB2, which is known to synergize with Runx2 to facilitate bone formation. The findings suggest Runx2-negative regulation of multiple miRs by a feed-forward mechanism to cause derepression of SATB2 to promote differentiation. We find also that miR-23a represses Runx2 in the terminally differentiated osteocyte, representing a feedback mechanism to attenuate osteoblast maturation. We provide direct evidence for an interdependent relationship among transcriptional inhibition of the miR cluster by Runx2, translational repression of Runx2 and of SATB2 by the cluster miRs during progression of osteoblast differentiation. Furthermore, miR cluster gain of function (i.e., inhibition of osteogenesis) is rescued by the exogenous expression of SATB2. Taken together, we have established a regulatory network with a central role for the miR cluster 23a∼27a∼24-2 in both progression and maintenance of the osteocyte phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980664      PMCID: PMC2993380          DOI: 10.1073/pnas.1007698107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

2.  SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation.

Authors:  Gergana Dobreva; Maria Chahrour; Marcel Dautzenberg; Laura Chirivella; Benoit Kanzler; Isabel Fariñas; Gerard Karsenty; Rudolf Grosschedl
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

3.  Production and purification of lentiviral vectors.

Authors:  Gustavo Tiscornia; Oded Singer; Inder M Verma
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  Mitotic bookmarking of genes: a novel dimension to epigenetic control.

Authors:  Sayyed K Zaidi; Daniel W Young; Martin A Montecino; Jane B Lian; Andre J van Wijnen; Janet L Stein; Gary S Stein
Journal:  Nat Rev Genet       Date:  2010-07-13       Impact factor: 53.242

5.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network.

Authors:  Mohammad Q Hassan; Rahul S Tare; Suk Hee Lee; Matthew Mandeville; Maria I Morasso; Amjad Javed; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

7.  Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects.

Authors:  Petcharat Leoyklang; Kanya Suphapeetiporn; Pichit Siriwan; Tayard Desudchit; Pattraporn Chaowanapanja; William A Gahl; Vorasuk Shotelersuk
Journal:  Hum Mutat       Date:  2007-07       Impact factor: 4.878

8.  High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.

Authors:  Valérie Geoffroy; Michaela Kneissel; Brigitte Fournier; Alan Boyde; Patrick Matthias
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development.

Authors:  Olga Britanova; Michael J Depew; Manuela Schwark; Bethan L Thomas; Isabelle Miletich; Paul Sharpe; Victor Tarabykin
Journal:  Am J Hum Genet       Date:  2006-08-30       Impact factor: 11.025

10.  Characterization and identification of microRNA core promoters in four model species.

Authors:  Xuefeng Zhou; Jianhua Ruan; Guandong Wang; Weixiong Zhang
Journal:  PLoS Comput Biol       Date:  2007-01-09       Impact factor: 4.475

View more
  162 in total

Review 1.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

2.  MicroRNAs control neurobehavioral development and function in zebrafish.

Authors:  Tamara L Tal; Jill A Franzosa; Susan C Tilton; Kenneth A Philbrick; Urszula T Iwaniec; Russell T Turner; Katrina M Waters; Robert L Tanguay
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

3.  MicroRNA signature associated with osteogenic lineage commitment.

Authors:  Behnaz Bakhshandeh; Masoud Soleimani; Maryam Hafizi; Seyed Hassan Paylakhi; Nasser Ghaemi
Journal:  Mol Biol Rep       Date:  2012-02-16       Impact factor: 2.316

Review 4.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

5.  MicroRNA 874-3p Exerts Skeletal Anabolic Effects Epigenetically during Weaning by Suppressing Hdac1 Expression.

Authors:  Priyanka Kushwaha; Vikram Khedgikar; Deepika Sharma; Tony Yuen; Jyoti Gautam; Naseer Ahmad; Anirudha Karvande; Prabhat R Mishra; Prabodh K Trivedi; Li Sun; Sanjay K Bhadada; Mone Zaidi; Ritu Trivedi
Journal:  J Biol Chem       Date:  2015-12-09       Impact factor: 5.157

Review 6.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

7.  MiR-351 negatively regulates osteoblast differentiation of MSCs induced by (+)-cholesten-3-one through targeting VDR.

Authors:  Qiuke Hou; Yongquan Huang; Yiwen Luo; Bin Wang; Yamei Liu; Rudong Deng; Saixia Zhang; Fengbin Liu; Dongfeng Chen
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells.

Authors:  Laleh S Arabanian; Fernando A Fierro; Friedrich Stölzel; Carolin Heder; David M Poitz; Ruth H Strasser; Manja Wobus; Martin Borhäuser; Ruben A Ferrer; Uwe Platzbecker; Matthias Schieker; Denitsa Docheva; Gerhard Ehninger; Thomas Illmer
Journal:  Haematologica       Date:  2014-02-28       Impact factor: 9.941

Review 9.  Runx2 and microRNA regulation in bone and cartilage diseases.

Authors:  Weiwei Zhao; Shanxing Zhang; Baoli Wang; Jian Huang; William W Lu; Di Chen
Journal:  Ann N Y Acad Sci       Date:  2016-08-15       Impact factor: 5.691

10.  miR-214 targets ATF4 to inhibit bone formation.

Authors:  Xiaogang Wang; Baosheng Guo; Qi Li; Jiang Peng; Zhijun Yang; Aiyuan Wang; Dong Li; Zhibo Hou; Ke Lv; Guanghan Kan; Hongqing Cao; Heng Wu; Jinping Song; Xiaohua Pan; Qiao Sun; Shukuan Ling; Yuheng Li; Mu Zhu; Pengfei Zhang; Songlin Peng; Xiaoqing Xie; Tao Tang; An Hong; Zhaoxiang Bian; Yanqiang Bai; Aiping Lu; Yinghui Li; Fuchu He; Ge Zhang; Yingxian Li
Journal:  Nat Med       Date:  2012-12-09       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.